Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). Annals of oncology : official journal of the European Society for Medical Oncology Wakelee, H., Reckamp, K. L., Leal, T. A., Patel, S. P., Blumenschein, G., Shum, E., Nieva, J., Oxnard, G., Sanborn, R. E., Waqar, S., Zeman, K., Dukart, G., Harrow, K., Liang, C., Holzhausen, A., Horn, L. 2018; 29 Suppl 8: viii541–viii542

View details for DOI 10.1093/annonc/mdy292.117

View details for PubMedID 32137409